Submitted recommendations
Submitted recommendations
Submitted recommendations
The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV of REACH (the "Authorisation List") and for these substances proposes Annex XIV entries (i.e. transitional arrangements and, where relevant, exemptions and review periods) to the European Commission, taking into account the opinion of the Member State Committee. The European Commission finally decides, by "comitology" procedure (with scrutiny), which substances will be included in Annex XIV and what the associated entries will be.
The below table includes all substances that have been included in ECHA's draft or final recommendations for inclusion of Candidate List substances in Annex XIV. The "Status"- column indicates whether the substances have been recommended for inclusion or are already included in Annex XIV. Documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.
Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
Submitted recommendations
- 10th Annex XIV recommendation 14 April 2021 [PDF][EN]
- 9th Annex XIV recommendation 1 October 2019 [PDF][EN]
- Amendment recommendation 10 July 2019 [PDF][EN]
- 8th Annex XIV recommendation 5 February 2018 [PDF][EN]
- 7th Annex XIV recommendation 10 November 2016 [PDF][EN]
- 6th Annex XIV recommendation 1 July 2015 [PDF][EN]
- 5th Annex XIV recommendation 6 February 2014 [PDF][EN]
- 4th Annex XIV recommendation 17 January 2013 [PDF][EN]
- 3rd Annex XIV recommendation 20 December 2011 [PDF][EN]
- 2nd Annex XIV recommendation 17 December 2010 [PDF][EN]
- 1st Annex XIV recommendation 1 June 2009 [PDF][EN]
There are currently no ongoing consultations.
| Octamethylcyclotetrasiloxane (D4) | 209-136-7 | 556-67-2 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Decamethylcyclopentasiloxane (D5) | 208-764-9 | 541-02-6 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Dodecamethylcyclohexasiloxane (D6) | 208-762-8 | 540-97-6 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Terphenyl, hydrogenated | 262-967-7 | 61788-32-7 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Dicyclohexyl phthalate (DCHP) | 201-545-9 | 84-61-7 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Disodium octaborate | 234-541-0 | 12008-41-2 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| Benzene-1,2,4-tricarboxylic acid 1,2-anhydride (trimellitic anhydride, TMA) | 209-008-0 | 552-30-7 | 10 (draft: March 2020; final: April 2021) | Recommended for inclusion in Annex XIV | |
| 4,4'-isopropylidenediphenol (bisphenol A; BPA) | 201-245-8 | 80-05-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP) with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (DOTE) | 239-622-4 | 15571-58-1 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (reaction mass of DOTE and MOTE) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 4,4'-bis(dimethylamino)-4''-(methylamino)trityl alcohol with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2) | 209-218-2 | 561-41-1 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Dioxobis(stearato)trilead | 235-702-8 | 12578-12-0 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Fatty acids, C16-18, lead salts | 292-966-7 | 91031-62-8 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Trilead dioxide phosphonate | 235-252-2 | 12141-20-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Sulfurous acid, lead salt, dibasic | 263-467-1 | 62229-08-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| [Phthalato(2-)]dioxotrilead | 273-688-5 | 69011-06-9 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Trilead bis(carbonate) dihydroxide | 215-290-6 | 1319-46-6 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Lead oxide sulfate | 234-853-7 | 12036-76-9 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Cyclohexane-1,2-dicarboxylic anhydride [1], cis-cyclohexane-1,2-dicarboxylic anhydride [2], trans-cyclohexane-1,2-dicarboxylic anhydride [3] [The individual cis- [2] and trans- [3] isomer substances and all possible combinations of the cis- and trans-isomers [1] are covered by this entry] |
201-604-9 236-086-3 238-009-9 |
85-42-7 13149-00-3 14166-21-3 |
9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Hexahydromethylphthalic anhydride [1], Hexahydro-4-methylphthalic anhydride [2], Hexahydro-1-methylphthalic anhydride [3], Hexahydro-3-methylphthalic anhydride [4] [The individual isomers [2], [3] and [4] (including their cis- and trans- stereo isomeric forms) and all possible combinations of the isomers [1] are covered by this entry] |
247-094-1 243-072-0 256-356-4 260-566-1 |
25550-51-0 19438-60-9 48122-14-1 57110-29-9 |
9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Tetraethyllead | 201-075-4 | 78-00-2 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 2-methoxyethanol | 203-713-7 | 109-86-4 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 2-ethoxyethanol | 203-804-1 | 110-80-5 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 1,2-benzenedicarboxylic acid, di-C6-10-alkyl esters; 1,2-benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5) |
271-094-0 272-013-1 |
68515-51-5 68648-93-1 |
8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 1-Methyl-2-pyrrolidone (NMP) | 212-828-1 | 872-50-4 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| 2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol (UV-327) | 223-383-8 | 3864-99-1 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) | 247-384-8 | 25973-55-1 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol (UV-350) | 253-037-1 | 36437-37-3 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV-320) | 223-346-6 | 3846-71-7 | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [1], 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [2] [covering any of the individual stereoisomers of [1] and [2] or any combination thereof] (karanal group) | - | - | 8 (draft: March 2017; final: February 2018) | Included in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear | 271-093-5 | 68515-50-4 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Dihexyl phthalate | 201-559-5 | 84-75-3 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Cyclohexane-1,2-dicarboxylic anhydride [1], cis-cyclohexane-1,2-dicarboxylic anhydride [2], trans-cyclohexane-1,2-dicarboxylic anhydride [3] [The individual cis- [2] and trans- [3] isomer substances and all possible combinations of the cis- and trans-isomers [1] are covered by this entry] |
201-604-9 236-086-3 238-009-9 |
85-42-7 13149-00-3 14166-21-3 |
7 (draft: November 2015; final: November 2016) | Not recommended in this round | |
| Hexahydromethylphthalic anhydride [1], Hexahydro-4-methylphthalic anhydride [2], Hexahydro-1-methylphthalic anhydride [3], Hexahydro-3-methylphthalic anhydride [4] [The individual isomers [2], [3] and [4] (including their cis- and trans- stereo isomeric forms) and all possible combinations of the isomers [1] are covered by this entry] |
247-094-1 243-072-0 256-356-4 260-566-1 |
25550-51-0 19438-60-9 48122-14-1 57110-29-9 |
7 (draft: November 2015; final: November 2016) | Not recommended in this round | |
| Trixylyl phosphate | 246-677-8 | 25155-23-1 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Sodium perborate; perboric acid, sodium salt |
239-172-9 234-390-0 |
- | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Sodium peroxometaborate | 231-556-4 | 7632-04-4 | 7 (draft: November 2015; final: November 2016) | Included in Annex XIV | |
| Orange lead (lead tetroxide) | 215-235-6 | 1314-41-6 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Lead monoxide (lead oxide) | 215-267-0 | 1317-36-8 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Pentalead tetraoxide sulphate | 235-067-7 | 12065-90-6 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Tetralead trioxide sulphate | 235-380-9 | 12202-17-4 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl esters, C7-rich | 276-158-1 | 71888-89-6 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters | 271-084-6 | 68515-42-4 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, dipentylester, branched and linear | 284-032-2 | 84777-06-0 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 1-bromopropane (n-propyl bromide) | 203-445-0 | 106-94-5 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 4-Nonylphenol, branched and linear, ethoxylated [substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof] | - | - | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| Acetic acid, lead salt, basic | 257-175-3 | 51404-69-4 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Anthracene oil | 292-602-7 | 90640-80-5 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
Tagged as:
(click the tag to search for relevant content)
EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.